Results per Page:
Novel chemoimmunotherapy approach shows promise for B-cell acute lymphoblastic leukemia in phase 1 study at Fred Hutch
DA-EPOCH plus inotuzumab ozogamicin was “safe and highly active” in adults with relapsed or refractory disease
‘Good cancer’? Views vary on a sunny phrase
Many patients and doctors refuse to apply the ‘g’ word to highly curable cancers, but some survivors draw hope from the ‘good’